Solute Carrier Family 7 (Amino Acid Transporter Light Chain, Y+L System), Member 7 Proteins (Slc7a7)

Human Solute Carrier Family 7 (Amino Acid Transporter Light Chain, Y+L System), Member 7 (Slc7a7) interaction partners

1. At present, 51 kinds of SLC7A7 gene mutations causing lysinuric protein intolerance have been found worldwide, including insert (C.1384-1385 ins (show INS Proteins) ACTA (show ACTA1 Proteins)), delete (C.1185-1188 del TTCT) and point mutations (P.R410X, P.Y457X, P.R 468X, P.L124p, etc).3, 4 In our cases, there were two heterozygous mutations in the SLC7A7 gene of the two sisters: C.1387 del C and IVS4+1C>T, which has never been reported worldwide.

2. The study reports a significant association between SLC7A7 rs12436190 and the risk of glioma in a Chinese population.

3. heteromerization of y+LAT1 and 4F2hc (show SLC3A2 Proteins) within the cell is not disrupted by any of the tested LPI mutations

4. SLC7A7 genetic variants are associated with increase risk for glioma in a Chinese population.

5. SLC7A7 plays a critical role in glioblastoma carcinogenesis and overexpression of SLC7A7 is correlated with worse outcomes in patients

6. SLC7A7/y+LAT1 mutations lead to a defective phenotype of macrophages resulting in lysinuric Protein Intolerance.

7. during differentiation of human monocytes from peripheral blood, SLC7A7 mRNA and system y(+)L activity are increased

8. novel SLC7A7 mutations in patients with lysinuric protein intolerance

9. expression levels and putative 5' promoter elements of the SLC7A7 gene

10. putative multiheteromeric structure of both [4F2hc/y(+)LAT-1] and [4F2hc/y(+)LAT-2], and the interference between y(+)LAT-1 and y(+)LAT-2 proteins may have a role in the pathogenesis of lysinuric protein intolerance

Mouse (Murine) Solute Carrier Family 7 (Amino Acid Transporter Light Chain, Y+L System), Member 7 (Slc7a7) interaction partners

1. The expression of Mct8 (show MCT8 Proteins) and L-type amino acid transporters Lat2 (show SLC7A8 Proteins) and Lat1 (show SLC7A5 Proteins) are determined in brain neurons during development.

2. Increased LAT1 (show SLC7A5 Proteins) expression can be induced by lipid oxidation products relevant to inflammatory responses in atherogenesis. LAT1 (show SLC7A5 Proteins) mediates lysophosphatidylcholine-enhanced cytokine production by endothelial cells.

3. selective regulation of SNAT3 (show SLC38A3 Proteins) and y(+)LAT1 expression may serve a major role in the renal adaptation to acid secretion and thus for systemic acid-base balance.

4. The Slc7a7(-/-) mouse displayed intrauterine growth restriction, leading to neonatal lethality. After heavy protein ingestion, the surviving adult animals presented metabolic derangement consistent with lysinuric protein intolerance.

5. LAT1 (show SLC7A5 Proteins), and LAT2 (show SLC7A8 Proteins) mRNAs were detected in fetal and postnatal femurs and in MC3T3-E1 cells, while OATP1 and NTCP (show SLC10A1 Proteins) mRNAs were not.